These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17474499)

  • 1. [Idiopathic venous thromboembolic disease. risk factors for recurrence in 2006].
    Christiaens L
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):133-8. PubMed ID: 17474499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
    Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
    Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Favaretto E; Palareti G
    Thromb Res; 2008; 122(5):610-7. PubMed ID: 18304616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of treatment of deep vein thrombosis: time for a new approach?
    Rychlik PG; Henry KS; Bussey HI
    Pharmacotherapy; 2005 Aug; 25(8):1112-5. PubMed ID: 16207102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
    Cosmi B; Palareti G
    Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism.
    Schulman S; Ogren M
    Thromb Haemost; 2006 Sep; 96(3):258-66. PubMed ID: 16953265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.
    Martinelli I; Bucciarelli P; Passamonti SM; Battaglioli T; Previtali E; Mannucci PM
    Circulation; 2010 Jun; 121(25):2740-6. PubMed ID: 20547928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of deep vein thrombosis.
    Couturaud F; Kearon C
    Semin Vasc Med; 2001; 1(1):43-54. PubMed ID: 15199513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?
    Siragusa S; Caramazza D; Malato A
    Br J Haematol; 2009 Mar; 144(6):832-7. PubMed ID: 19183183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA; Chomo DL
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombophilic conditions in the pathogenesis of venous thromboembolism].
    Poul H
    Vnitr Lek; 2006 Mar; 52 Suppl 1():17-25. PubMed ID: 16637445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of oral anticoagulant treatment on D-dimers levels].
    Ombandza-Moussa E; Samama MM; Horellou MH; Chatelier AL; Elalamy I; Conard J
    Ann Biol Clin (Paris); 2001; 59(5):579-83. PubMed ID: 11602388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended treatment for venous thromboembolism: how long is long enough?
    Cosmi B; Palareti G
    Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
    Galanaud JP; Sevestre-Pietri MA; Bosson JL; Laroche JP; Righini M; Brisot D; Boge G; van Kien AK; Gattolliat O; Bettarel-Binon C; Gris JC; Genty C; Quere I;
    Thromb Haemost; 2009 Sep; 102(3):493-500. PubMed ID: 19718469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.